At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of a Questionnaire as a Screening Tool to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
In Brief
An observational study for Nephrogenic Systemic Fibrosis. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The Primary Aim of this study is to validate a questionnaire as a screening tool to identify subjects with symptoms suggestive of nephrogenic systemic fibrosis (NSF). The investigators believe that there will be difference between subjects with NSF and other skin conditions and normal skin.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNephrogenic Systemic Fibrosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2009
First PostedMar 2009
Primary CompletionSep 2010
TodayJul 2026
First PostedMar 26, 2009
Enrollment StartMar 1, 2009
Primary CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 17.3 years ago